Monday, May 28, 2018

Macquarie upgraded Sun Pharma to ‘Neutral’ from ‘Underperform’ with a target price of Rs 460.

from Stocks-Markets-The Economic Times https://ift.tt/2kwdZyo

0 comments:

Post a Comment

Followers

Contact Form

Name

Email *

Message *

Popular Posts

FOLLOW BY EMAIL

Enter your email address:

Delivered by FeedBurner